KR20160109782A - A Patch Have Dissolve Skill of Cellulite and Underwear Skill for Revision - Google Patents
A Patch Have Dissolve Skill of Cellulite and Underwear Skill for Revision Download PDFInfo
- Publication number
- KR20160109782A KR20160109782A KR1020150034836A KR20150034836A KR20160109782A KR 20160109782 A KR20160109782 A KR 20160109782A KR 1020150034836 A KR1020150034836 A KR 1020150034836A KR 20150034836 A KR20150034836 A KR 20150034836A KR 20160109782 A KR20160109782 A KR 20160109782A
- Authority
- KR
- South Korea
- Prior art keywords
- parts
- weight
- cellulite
- patch
- resin adhesive
- Prior art date
Links
- 208000035484 Cellulite Diseases 0.000 title claims abstract description 36
- 206010049752 Peau d'orange Diseases 0.000 title claims abstract description 36
- 230000036232 cellulite Effects 0.000 title claims abstract description 35
- 239000000853 adhesive Substances 0.000 claims abstract description 29
- 230000001070 adhesive effect Effects 0.000 claims abstract description 28
- 239000000203 mixture Substances 0.000 claims abstract description 22
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000004744 fabric Substances 0.000 claims abstract description 14
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims abstract description 11
- 229940108924 conjugated linoleic acid Drugs 0.000 claims abstract description 11
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 11
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 11
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229960001948 caffeine Drugs 0.000 claims abstract description 8
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000003921 oil Substances 0.000 claims abstract description 6
- 239000004677 Nylon Substances 0.000 claims abstract description 5
- 244000269722 Thea sinensis Species 0.000 claims abstract description 5
- 235000009569 green tea Nutrition 0.000 claims abstract description 5
- 239000002480 mineral oil Substances 0.000 claims abstract description 5
- 235000010446 mineral oil Nutrition 0.000 claims abstract description 5
- 229920001778 nylon Polymers 0.000 claims abstract description 5
- 229920002635 polyurethane Polymers 0.000 claims abstract description 5
- 239000004814 polyurethane Substances 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 5
- 239000011347 resin Substances 0.000 claims abstract description 5
- 229920005989 resin Polymers 0.000 claims abstract description 5
- 240000008530 Rosa canina Species 0.000 claims abstract description 4
- 235000000539 Rosa canina Nutrition 0.000 claims abstract description 4
- ISQRJFLLIDGZEP-CMWLGVBASA-N Sophoricoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C=2C(C3=C(O)C=C(O)C=C3OC=2)=O)C=C1 ISQRJFLLIDGZEP-CMWLGVBASA-N 0.000 claims abstract description 4
- ISQRJFLLIDGZEP-KJRRRBQDSA-N Sophoricoside Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1ccc(C=2C(=O)c3c(O)cc(O)cc3OC=2)cc1 ISQRJFLLIDGZEP-KJRRRBQDSA-N 0.000 claims abstract description 4
- 229940073466 garcinia cambogia fruit extract Drugs 0.000 claims abstract description 4
- 238000005096 rolling process Methods 0.000 claims abstract description 4
- 229940081390 isomerized safflower acid Drugs 0.000 claims abstract description 3
- 239000004925 Acrylic resin Substances 0.000 claims description 14
- 229920000178 Acrylic resin Polymers 0.000 claims description 14
- 230000009467 reduction Effects 0.000 claims description 12
- 230000001461 cytolytic effect Effects 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000000354 decomposition reaction Methods 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 18
- 210000003491 skin Anatomy 0.000 description 17
- 235000019197 fats Nutrition 0.000 description 15
- 208000008589 Obesity Diseases 0.000 description 13
- 210000001217 buttock Anatomy 0.000 description 12
- 235000020824 obesity Nutrition 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 210000001015 abdomen Anatomy 0.000 description 11
- 239000000654 additive Substances 0.000 description 11
- 230000000996 additive effect Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 210000000577 adipose tissue Anatomy 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 210000000689 upper leg Anatomy 0.000 description 5
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000012937 correction Methods 0.000 description 4
- 235000021588 free fatty acids Nutrition 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 241000220317 Rosa Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000593508 Garcinia Species 0.000 description 2
- 235000000885 Garcinia xanthochymus Nutrition 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000008204 material by function Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 150000005830 nonesterified fatty acids Chemical class 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- AGNTUZCMJBTHOG-UHFFFAOYSA-N 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol Chemical compound OCC(O)COCC(O)COCC(O)CO AGNTUZCMJBTHOG-UHFFFAOYSA-N 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 240000006162 Chenopodium quinoa Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000109365 Rosa arkansana Species 0.000 description 1
- 235000005066 Rosa arkansana Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 102000000019 Sterol Esterase Human genes 0.000 description 1
- 108010055297 Sterol Esterase Proteins 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 125000005396 acrylic acid ester group Chemical group 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229940124826 caffeine supplement Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- -1 ester fatty acid Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012907 medicinal substance Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 229950006451 sorbitan laurate Drugs 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/023—Adhesive bandages or dressings wound covering film layers without a fluid retention layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0246—Adhesive bandages or dressings characterised by the skin-adhering layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
The present invention relates to a patch having a function for undergarment correction and cellulite decomposing function, and more particularly, to a patch having a cellulite decomposing component by including it in an adhesive to be adhered to the skin of the body, It has a function of undergarment for correction and a function of correction undergarment which can effectively combine the body fat accumulated in the body attached to the specific part of the body and the abutment of the abdomen and the buttocks, To a patch having a decomposition function.
Obesity is consumed in the calories consumed, the remaining part of the body is converted to fat, various parts of the body, especially subcutaneous tissue and accumulation in the abdominal cavity.
Triglycerides (TG, triglycerol) is a compound in which fatty acids of glycerin and three molecules are ester-bonded. It is a neutral fat synthesized from carbohydrates. It is stored in animal fat tissues and thus releases free fatty acids into the blood by enzymatic hydrolysis.
Neutral fat stored in adipose tissue is broken down into nonesterified fatty acid (NEFA) and glycerol when glucose is lacking as an energy source and released into the blood.
The non-ester fatty acid that is used as an energy source is changed from liver to triglyceride again.
When it enters the blood again, it is called endogenous triglyceride.
Excessive amounts of triglycerides are closely related to atherosclerosis and coronary artery disease.
Patients with obesity are those who have accumulated much more fat in the body than the amount of fat needed for the function of the fat tissue, and this is the person who has a disability in normal biochemical and physiological functions in the body.
Obesity not only causes various diseases such as diabetes, hyperlipidemia, hypertension and coronary artery disease, and joint disease, but it also makes normal social life impossible.
In recent years, there has been a growing interest in obesity, and new methods and adjuvant methods have been used for prevention and treatment of obesity as well as scientific training methods. There have been various attempts to prove the effect of this method in various ways .
Among them, caffeine, which is known as an adjunct of fat decomposition, is recently used by elite athletes and amateur athletes as an athletic function supplement. In addition, caffeine can increase the use of free fatty acids and can expect a glycogen-saving effect, .
However, when caffeine supplement is orally administered, side effects such as progression, nausea, insomnia, and irritability due to systemic side effects as well as drug efficacy and withdrawal symptoms when prolonged use are exhibited.
Also, due to the inconvenience of use in subcutaneous injection, local application of a certain drug concentration is difficult.
Therefore, when caffeine is administered by transdermal absorption, it is possible not only to reduce such side effects but also to avoid gastrointestinal disturbance because it does not pass through the gastrointestinal tract and also avoids first pass.
It is also known that the drug can be continuously delivered at a constant rate, so that the applicant can easily use the drug and can easily stop the administration of the drug if necessary.
In addition, when administered to the target site, it is absorbed only by the site, and there are various advantages that can concentrate many drugs on the target site. Also, to normalize the action of moving jaw muscles, Kinesio taping, which promotes circulation of blood, lymph and tissue fluid, is widely used in sports and everyday life, and is widely used because of its ease of application without any adverse side effects.
On the other hand, obesity as described above is concentrated in the abdomen, side of the body, forearm, thigh, and buttocks of the body, and the portion where the obesity is formed is uneven in appearance.
Therefore, it is necessary to develop a body patch that can concentrate on the rugged parts that it wants to conceal, and some are also on the market.
Other examples of functional materials known as body patches as described above include adenosine, sodium hyaluronate, collagen peptide, Huangchil extract, a mixture of sorbitan laurate and lauroyl plurone, and a mixture of butylene glycol and quinoa extract Is known to be used.
In addition, there are many suggestions for extracting functional materials that have the effect of decomposing fat in various oriental medicines and applying them to patches. However, most of them provide nutrients to the skin or supply nutrients containing moisture to the skin, , That is, it was mainly focused on beauty rather than aiming to help obesity.
SUMMARY OF THE INVENTION Accordingly, it is an object of the present invention to provide a composition containing a cellulite degrading component in an adhesive of a patch to be adhered to the skin of the body, Which is capable of effectively decomposing body fat accumulated in the body by a composition having a cellulolytic component, and a patch having a cellulite decomposing function.
It is another object of the present invention to provide a method for producing a cellulite-degrading composition which comprises a composition having a cellulolytic component in contact with the skin of a body and comprising an adhesive in a patch to be attached to the abdomen, And to provide a patch having cellulite decomposing function and a correction underwear function capable of effectively disassembling the cellulite accumulated in the abdomen.
It is a further object of the present invention to provide a method for preventing and treating obesity, which comprises applying a composition containing a cellulolytic component to a patch of a patch to be adhered to the skin of the body and attaching the adhesive to the buttocks, And a patch having cellulite decomposing function, which is capable of effectively decomposing body fat accumulated in the buttocks.
In order to accomplish the above object, the present invention provides a method for manufacturing a resin adhesive, comprising applying a resin adhesive containing a cellulolytic composition on one side of a fabric made of nylon 70 to 80%
A modified example for effectively implementing the object of the embodiment is that the acrylic resin adhesive comprises 90 to 95 parts by weight of acrylic acid AR-432F as a main component and acrylic acid AR-430F as a curing agent in a ratio of 100: 0.5 to 3.0 5 to 10 parts by weight of the cellulite reducing adjuvant is mixed and aged at a temperature of 50 to 70 ° C for 20 to 30 hours and then the release film is adhered to the back surface thereof.
The present invention having the above-described configuration realizes the following effects.
First, a composition with a cellulolytic component is prepared by incorporating a composition having a cellulite degradation component into the adhesive of a patch to be adhered to the skin of the body and attaching the adhesive to a specific site of the body where the body fat has accumulated Effectively dissolves body fat accumulated in the body.
Second, a composition having a cellulolytic component is included in a pressure-sensitive adhesive of a patch to be adhered to the skin of the body, and the pressure-sensitive adhesive is brought into contact with the abdomen and then pulled and attached to the abdomen, It effectively breaks down cellulite.
Third, the composition having the cellulolytic component is contained in the adhesive of the patch to be adhered to the skin of the body, and the adhesive is attached to the buttocks and pulled toward the waist to attach the visceral effect. Effectively dissolves body fat accumulated in the buttocks.
1 is a perspective view showing an example of the present invention.
Fig. 2 is a view showing an example of use of the present invention
Figure 3 is a cross-sectional view of another embodiment of the present invention
As shown in FIG. 1, the
When the
In addition, the acrylic resin adhesive 20 functions as a pressure-sensitive adhesive adhering to the skin of the body in a state where the acrylic resin adhesive 20 is formed on the
That is, the
The main component of the acrylic resin adhesive 20 functioning as a pressure-sensitive adhesive is acrylic acid ester.
The acrylic resin adhesive (20) is characterized in that it has excellent adhesive strength and is well adhered to the flat part as well as the bending part, has excellent cohesive strength, has an advantage of maintaining the adhesive state for a long time and does not appear on the skin when peeling off.
In addition, the acrylic resin adhesive 20 has no skin irritation and does not cause skin troubles.
The
5 to 10 parts by weight of the cellulite reducing auxiliary additive is mixed with 90 to 95 parts by weight of the acrylic resin adhesive agent stirred by the stirrer as described above and then coated on one side of the
The releasing
The main additive of the cellulite reducing supplement additive applied in the present invention is conjugated linoleic acid or safflower oil.
Conjugated Linoleic Acid (or conjugated linoleic acid) or Isomerized Safflower Acid is mixed at a ratio of 30 to 70 parts by weight, and conjugated linoleic acid (CLA) is currently being studied in various aspects .
It has been found that conjugated linoleic acid plays a diverse and effective role in preventing cancer, inhibiting arteriosclerosis, reducing blood cholesterol, and antioxidant activity.
In addition, the conjugated linoleic acid activates lipase in adipocytes and uses the fat as an energy source to increase the protein called 'UCP', which converts fat into heat. It also acts to prevent fat from mixing into adipocytes, It is said that it works for anxious person.
The conjugated linoleic acid acts on an enzyme called hormone-sensitive lipase that turns accumulated fat into energy and produces energy, and by decomposing and consuming fat, it has an effect of fat burning such as exercise, thereby preventing and improving obesity and being effective in diet It was announced.
10 to 30 parts by weight of mineral oil is added as a second additive for cellulite reduction assisting.
The mineral oil is a by-product produced during refining of crude oil, and its main constituents are alkane and paraffin.
10 to 30 parts by weight of Rosa Canina Fruit Oil is added as a third additive for cellulite reduction aids.
The Rose Hip Fruit Oil is extracted from the fruit of wild rose (Rosa Canina) and contains a large amount of essential fatty acids, linolenic acid and vitamin C. It is known that there is excellent efficacy in external cell regeneration, cell membrane enhancement, sebaceous gland control, problematic skin convergence, and soothing.
In addition, the rose hip tea oil is rich in carotene, and carotene is partially converted into vitamin a in the body, which has a good effect on the skin tissue and mucosa. As a result, the rose hip tea oil prevents the cold and prevents aging. The effect is also known.
It is also known that pectin, a component of roseheed fruit oil, is effective in helping to release harmful substances inside the body, thereby preventing cancer and helping to break down body fat.
1 to 5 parts by weight of Garcinia Cambogia Fruit Extract is added as a fourth additive for cellulite reduction aids.
The Garcinia fruit extract is extracted from the fruit of Garcinia, and is known as a substance which inhibits the synthesis of carbohydrate into fat to help reduce body fat and to prevent the absorption of fat from the body.
1 to 5 parts by weight of sophoricoside is added as a fifth additive which is another additive for cellulite reduction aids, and 2 to 8 parts by weight of green tea powder or caffeine is mixed as a sixth additive.
The soporicoside is extracted from the fig tree, which is a fruit of the fruit tree, and has a weight loss effect and a body fat reduction effect, and the content of cholesterol and triglyceride in the blood is remarkably lowered.
The cornice is classified as a material that can be used as a food material in KFDA, and is a medicinal substance which has been used in Dongbu Bohmun and Hoseok Gangmok.
Caffeine or green tea powder, a sixth additive for cellulite reduction aids, is a substance that exhibits significant physiological effects.
A patch consisting of the above composition was submitted to SMC-150306-4065 for examination at the Clinical Support Center of Oriental Biotechnology Industry, SEM.
Those who have been using the skin for more than one month with steroids for the treatment of skin disease, those who have not passed six months after participating in the same test, those who are pregnant or breastfeeding and those who are pregnant, skin diseases, allergies, , Those with irritable skin, and those with atopic dermatitis were excluded.
The subjects were selected among 20 adult women aged 30 to 50 who had a body mass index (BMI) of 18 or more and 20 persons who had a standard photograph of cellulite grade 1, Was 30 days.
In addition, the subject's test site was attached with patch fabric (10) on the femur and abdomen with cellulite.
After four weeks of using the product, the test evaluated the general evaluation (feelings of use), favorability evaluation, efficacy (temporary cellulite reduction effect) evaluation of the test product, It was evaluated by survey evaluation, and it was evaluated as positive and satisfactory.
In the present invention, however, only the reduced effect of the cellulite on the patches before and after the patch fabric is attached to the abdomen and hips of the subject and the patch fabric is removed after the test is completed is explained based on accurate data.
The cellulite reduction rate was analyzed by the following equation.
(Equation)
Table 1 shows the age ranges of subjects participating in the test.
Table 1 shows that the subjects adhered patches according to the present invention to obesity-accumulating parts of the body for four weeks and measured them every two weeks.
Table 1
The subjects participating in the test were 39.8 years old, 50% in their 30s, 45% in their 40s and 5% in their 50s.
Table 2
Statistical analysis of the visual evaluation after use of the product revealed that there was a statistically significant level of temporary cellulite reduction effect after 4 weeks of use of the product.
Table 3
Statistical analysis of dendritic and subcutaneous lipid interface length measurements after product use showed statistically significant levels of temporary cellulite reduction after 4 weeks of product use.
Table 4
As a result of the reduction rate of the interface length between dermis and subcutaneous fat layer after using the product, it was 0.788% after 2 weeks of use and 4.302% after 4 weeks of using the product.
In addition, the patch according to the invention was attached to the abdomen, thighs and buttocks of the body where the obesity layer was accumulated, and was checked over a period of 4 weeks at intervals of 2 weeks. As a result, The effect was confirmed, and it was confirmed that the cellulite layer in the part where the patch was attached, that is, the abdomen, the thigh and the buttocks, was partially destroyed.
Further, in the present invention, a patch having a cellulolytic function was adhered to the buttocks of the same subjects, i.e., the thigh with the cellulite, and then the test was performed.
The left part of the buttocks was selected for the test site, and Moire, which is the wave pattern on the highest part of the buttocks, is divided firstly into three sections (L1, L2, L3) up to the fourth Moire.
Table 5
The results were analyzed by using the image analyzer (Image-pro® plus, USA) to measure the length of each section of the 4th Moire in the first Moire Respectively.
The smaller the number of each section, the better the temporary hip line improvement effect.
The measured value (length, AU) analyzed with an image analyzer (Image-pro® plus, USA) is as follows.
Table 6-1
Table 6-2
Table 6-3
Table 7
The change in the hipline of the test product over time after use was calculated to calculate the temporary hipline improvement rate (%) before use of the product. The results are as follows.
The heap line improvement rate was analyzed by the following equation.
(Equation)
The temporary heap line improvement rates are shown in Tables 8 to 9 below.
Table 8
Table 9
As described above, the subjects were selected from among persons aged 30 to 50 years who had a body mass index (BMI) of 18 or more and 20 persons who had a cellulite determination grade 1 or higher (Standard photograph) As a result of the test on the test product, the results of the questionnaire were evaluated that there was no trouble in the skin, and the feeling, the feeling of good use, and the degree of satisfaction were mostly satisfactory.
It will be understood by those skilled in the art that the present invention may be embodied in many other specific forms without departing from the spirit or essential characteristics thereof.
Therefore, it should be understood that the above-described embodiments are to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than the foregoing description, It is intended that all changes and modifications derived from the equivalent concept be included within the scope of the present invention.
10: Patch Fabric 20: Acrylic resin adhesive
30: release film
Claims (2)
The cellulolytic composition,
30 to 70 parts by weight of any one of Conjugated Linoleic Acid and Isomerized Safflower Acid;
10 to 30 parts by weight of a mineral oil;
10 to 30 parts by weight of Rosa Canina Fruit Oil;
1 to 5 parts by weight of Garcinia Cambogia Fruit Extract;
1 to 5 parts by weight of Sophoricoside; And
Characterized in that 1 to 8 parts by weight of a mixture of one or both of caffeine and green tea powder is mixed with a patch for cellulite decomposition.
In the acrylic resin adhesive,
5 to 10 parts by weight of a cellulite reduction aid is mixed with 90 to 95 parts by weight of a mixture of a main acrisol AR-432F and a curing agent acrisol AR-430F at a ratio of 100: 0.5 to 3.0, Deg.] C for 20 to 30 hours, and a releasing film adhered to the back surface thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150034836A KR20160109782A (en) | 2015-03-13 | 2015-03-13 | A Patch Have Dissolve Skill of Cellulite and Underwear Skill for Revision |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150034836A KR20160109782A (en) | 2015-03-13 | 2015-03-13 | A Patch Have Dissolve Skill of Cellulite and Underwear Skill for Revision |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20160109782A true KR20160109782A (en) | 2016-09-21 |
Family
ID=57079973
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150034836A KR20160109782A (en) | 2015-03-13 | 2015-03-13 | A Patch Have Dissolve Skill of Cellulite and Underwear Skill for Revision |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20160109782A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102579283B1 (en) * | 2023-04-06 | 2023-09-19 | 김관중 | Vitamin-containing hydrogel patch |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150006765A (en) | 2013-07-08 | 2015-01-19 | 주식회사 하나스포츠 | composition of caffeine tape for body slimming |
-
2015
- 2015-03-13 KR KR1020150034836A patent/KR20160109782A/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150006765A (en) | 2013-07-08 | 2015-01-19 | 주식회사 하나스포츠 | composition of caffeine tape for body slimming |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102579283B1 (en) * | 2023-04-06 | 2023-09-19 | 김관중 | Vitamin-containing hydrogel patch |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2008266971B2 (en) | Topical composition for treating pain | |
WO2006120066A1 (en) | Self-adhesive skin patch and combination set for cosmetic skin care | |
WO2006062748A3 (en) | Omega-3 fatty acids and dyslipidemic agent for lipid therapy | |
CN113440440B (en) | Skin barrier repair composition and preparation method and application thereof | |
ES2340510T3 (en) | USE OF RENTAL-FURANS FOR THE PREPARATION OF A MEDICINAL PRODUCT INTENDED FOR THE TREATMENT OF OBESITY AND FOR THE COSMETIC TREATMENT OF THE EXCEESS OF WEIGHT. | |
EP3107511A1 (en) | Adhesive film bandage for medical compression | |
KR102159427B1 (en) | Cosmetic methods and therapeutic uses for fat reduction | |
US20190160116A1 (en) | Dermatologic composition containing escherichia coli and enterococcus faecalis | |
KR20160109782A (en) | A Patch Have Dissolve Skill of Cellulite and Underwear Skill for Revision | |
CN105126037B (en) | A kind of ointment for treating bone fracture and injury of the extract containing natural component and preparation method thereof | |
KR20150006765A (en) | composition of caffeine tape for body slimming | |
US20180207078A1 (en) | Combination of natural substances comprising at least one glycyrrhetinic acid and at least one guggulsterone, and use thereof for cosmetic applications | |
JP2009057290A (en) | Hyaluronic acid production promoter | |
WO2006007675A1 (en) | Cholic acid and/or its derivatives for the reduction of localized fat in the human body | |
WO2003047610A1 (en) | Composition and method to increase female sexual desire and sexual satisfaction | |
CN1824246A (en) | Medicinal film vest medicinal film plaster for treating coronary heart disease stenocardia and preventing myocardial infaction and its preparation method | |
CN108451991A (en) | A kind of psoriasis formula and preparation method thereof | |
KR20020089251A (en) | A composition applicable to a skin for diet and an application thereof | |
KR101033116B1 (en) | Caffeine tape for body slimming | |
KR20150129735A (en) | Bimatoprost for enhancement of leptin production | |
KR20230174698A (en) | Pharmaceutical composition for the treatment of pain containing hemp seed oil as an active ingredient | |
JP2012111740A (en) | Skin care external preparation for slimming, and method for utilizing the same | |
CN103550410A (en) | Drug composition for losing weight, preparation containing same and preparation method of drug composition | |
Arasiewicz et al. | Pathologies of the skin and its appendages in endocrine diseases | |
Hernández-Pérez et al. | 10 Golden Lift “in the Management of Cellulite |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |